Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.57
-0.01 (-0.63%)
At close: Aug 15, 2025, 12:38 PM
Mangoceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | 109.31K | 105.25K | 133.37K | 163.16K | 214.09K | 244.37K | 245.16K | 141.24K | 100.72K | 8.94K | n/a | n/a | n/a | n/a |
Cost of Revenue | 47.24K | 25.14K | 50.7K | 93.37K | 66.7K | 101.79K | 100.57K | 54.11K | 43.52K | 4.09K | n/a | n/a | n/a | n/a |
Gross Profit | 62.06K | 80.1K | 82.67K | 69.79K | 147.4K | 142.58K | 144.59K | 87.13K | 57.2K | 4.85K | n/a | n/a | n/a | n/a |
Operating Income | -4.85M | -1.68M | -1.76M | -2.17M | -2.37M | -2.57M | -1.8M | -2.29M | -2.56M | -671.86K | -992K | -328K | -18.71K | -17.52K |
Interest Income | 13.7K | n/a | n/a | n/a | n/a | n/a | n/a | 8.23K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -673.65K | -995K | -329K | -19.6K | -17.7K |
Net Income | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -673.65K | -995K | -329K | -19.6K | -17.7K |
Selling & General & Admin | 3.5M | 1.74M | 1.59M | 2.2M | 2.37M | 2.38M | 1.69M | 2.29M | 2.52M | 676.71K | 960.4K | 327.9K | 18.71K | 17.52K |
Research & Development | n/a | 171.86K | n/a | n/a | 171.86K | 333.44K | n/a | 131.42K | n/a | n/a | 31.42K | n/a | n/a | n/a |
Other Expenses | 3.07M | -584.41K | 255K | 40K | n/a | n/a | 255.5K | n/a | 92.5K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.89M | 1.76M | 1.84M | 2.24M | 2.52M | 2.71M | 1.94M | 2.38M | 2.62M | 676.71K | 991.83K | 327.9K | 18.71K | 17.52K |
Interest Expense | n/a | n/a | 241.62K | 222.68K | n/a | n/a | n/a | n/a | 1.76K | 1.8K | 3.09K | 1.58K | 889.00 | 181.00 |
Selling & Marketing Expenses | 281.73K | 145.71K | 251.33K | 229.24K | 852.38K | 463.98K | 720.53K | 797.26K | 284.36K | n/a | 98.8K | n/a | n/a | n/a |
Cost & Expenses | 4.92M | 1.78M | 1.89M | 2.33M | 2.58M | 2.81M | 2.04M | 2.43M | 2.66M | 680.79K | 991.83K | 327.9K | 18.71K | 17.52K |
Income Tax Expense | n/a | 40.00 | n/a | n/a | -40 | n/a | n/a | n/a | n/a | -3.86K | n/a | n/a | n/a | -71.39K |
Shares Outstanding (Basic) | 1.98M | 1.98M | 2.01M | 1.74M | 1.52M | 1.3M | 1.06M | 1.05M | 750.56K | 885.78K | 997.67K | 997.67K | 997.67K | 997.67K |
Shares Outstanding (Diluted) | 1.98M | 1.98M | 2.01M | 1.74M | 1.52M | 1.3M | 1.06M | 1.05M | 750.56K | 885.78K | 997.67K | 997.67K | 997.67K | 997.67K |
EPS (Basic) | -2.45 | -0.98 | -0.99 | -1.35 | -1.56 | -1.98 | -1.7 | -2.17 | -3.41 | -0.76 | -1 | -0.33 | -0.02 | -0.02 |
EPS (Diluted) | -2.45 | -0.98 | -0.99 | -1.35 | -1.5 | -1.98 | -1.7 | -2.1 | -3.41 | -0.76 | -1 | -0.33 | -0.02 | -0.02 |
EBITDA | -4.85M | -1.68M | -1.76M | -2.17M | -2.36M | -2.56M | -1.79M | -2.28M | -2.55M | -667.99K | -991.83K | -328K | -18.71K | -17.52K |
EBIT | -4.85M | -2.4M | -1.76M | -2.17M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -671.86K | -992K | -328K | -18.71K | -17.52K |
Depreciation & Amortization | n/a | 721.79K | 252.00 | 3.21K | 6.22K | 6.29K | 6.29K | 6.22K | 6.08K | 3.86K | n/a | n/a | n/a | n/a |